While allergic features were slightly less frequent in the RAC2 GTPase patients (52.8%, particularly with asthma diagnosis), 35.3% of the individuals displayed at least one lymphoproliferative manifestation, which was significantly higher than that of the other groups (p = 0.001). The gene discussed is RAC2; the disease is asthma.